Growth Metrics

Regeneron Pharmaceuticals (REGN) Cash from Investing Activities Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 116.52%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 38.24%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -22.09%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 30.54%
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -22.09%
Dec 31, 2025 28.43%
Sep 30, 2025 -59.99%
Jun 30, 2025 -38.26%
Mar 31, 2025 33.51%
Dec 31, 2024 29.55%
Sep 30, 2024 38.24%
Jun 30, 2024 -85.95%
Mar 31, 2024 -16.79%
Dec 31, 2023 39.90%
Sep 30, 2023 13.83%
Jun 30, 2023 -53.86%
Mar 31, 2023 18.98%
Dec 31, 2022 -107.25%
Sep 30, 2022 43.08%
Jun 30, 2022 20.89%
Mar 31, 2022 -30.01%
Dec 31, 2021 -96.35%
Sep 30, 2021 -104.13%
Jun 30, 2021 31.22%
Mar 31, 2021 -35.53%
Dec 31, 2020 3.15%
Sep 30, 2020 -29.30%
Jun 30, 2020 119.18%
Mar 31, 2020 -46.78%
Dec 31, 2019 8.37%
Sep 30, 2019 20.10%
Jun 30, 2019 -36.88%
Mar 31, 2019 -160.93%
Dec 31, 2018 -29.20%
Sep 30, 2018 -0.41%
Jun 30, 2018 -9.28%
Mar 31, 2018 -48.66%
Dec 31, 2017 -99.39%
Sep 30, 2017 -42.87%
Jun 30, 2017 -12.99%
Mar 31, 2017 15.97%
Dec 31, 2016 -35.12%
Sep 30, 2016 -23.69%
Jun 30, 2016 -68.63%
Mar 31, 2016 33.37%
Dec 31, 2015 -49.68%
Sep 30, 2015 -79.75%
Jun 30, 2015 -38.73%
Mar 31, 2015 -116.96%
Dec 31, 2014 54.26%
Sep 30, 2014 -414.62%
Jun 30, 2014 -41.39%
Mar 31, 2014 -138.76%
Dec 31, 2013 32.32%
Sep 30, 2013 -84.44%
Jun 30, 2013 212.55%
Mar 31, 2013 -2.68%
Dec 31, 2012 89.01%
Sep 30, 2012 -53.53%